(TSX:BLCO)

24.42 UNCHANGED

Delayed Quote Updated: 11:13 AM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BLCO

< Previous 1 2 3 4 5 6 Next >

Bausch + Lomb Announces Presentation of New Data at the Association for Research in Vision and Ophthalmology Annual Meeting

April 29, 2024

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Announces Statistically Significant Results From a Clinical Study of a Novel Daily Nutritional Supplement for Dry Eyes

April 25, 2024

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Reports More Than 84 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through Innovative Recycling Programs

April 18, 2024

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Will Release First-Quarter 2024 Financial Results on May 1

April 15, 2024

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Will Present New Scientific Data and Analyses at the American Society of Cataract and Refractive Surgery Annual Meeting

March 27, 2024

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Announces Appointment of Karen L. Ling to Board of Directors

February 28, 2024

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Announces Fourth-Quarter and Full-Year 2023 Results and Provides 2024 Guidance

February 21, 2024

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2023 Financial Results on February 21

February 05, 2024

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Receives FDA Approval for TENEO™ Excimer Laser Platform for Myopia and Myopic Astigmatism LASIK Vision Correction Surgery

January 08, 2024

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

January 03, 2024

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Reports More Than 76 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue® Eye Care Recycling Programs

November 15, 2023

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Announces Third-Quarter 2023 Results and Raises Full-Year 2023 Guidance

November 01, 2023

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Will Present New Scientific Data and Analyses at American Academy of Ophthalmology Annual Meeting

October 26, 2023

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Will Release Third-Quarter 2023 Financial Results on November 1

October 16, 2023

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Will Present New Scientific Data and Analyses at American Academy of Optometry Annual Meeting

October 04, 2023

From Bausch + Lomb

Via Business Wire

Bausch Health's Bausch + Lomb Announces Completion of the Acquisition of XIIDRA(R)

September 29, 2023

Via ACCESSWIRE

Bausch + Lomb Completes Acquisition of XIIDRA®

September 29, 2023

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Launches LUMIFY EYE ILLUMINATIONS™ in the United States

September 26, 2023

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb’s ONE by ONE and Biotrue® Eye Care Recycling Programs Recognized As Sustainability Service of the Year Award Winners

September 20, 2023

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Announces Pricing of Senior Secured Notes Offering

September 14, 2023

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Launches MIEBO™ (Perfluorohexyloctane Ophthalmic Solution) in the United States

September 12, 2023

From Bausch + Lomb Corporation

Via Business Wire

Bausch Health's Bausch + Lomb Announces Launch of Proposed Financing for Acquisition of XIIDRA(R)

September 11, 2023

Via ACCESSWIRE

Bausch + Lomb Announces Launch of Proposed Financing for Acquisition of XIIDRA®

September 11, 2023

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Announces Disclosure of Historical and Pro Forma Financial Information With Respect to Acquisition of XIIDRA®

September 06, 2023

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Will Present New Scientific Data on its Surgical Products and Pipeline at European Society of Cataract and Refractive Surgery Annual Meeting

September 06, 2023

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Will Participate at the 2023 Wells Fargo Healthcare Conference

August 29, 2023

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Announces Expiration of Hart-Scott-Rodino Waiting Period for Acquisition of XIIDRA®

August 24, 2023

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Announces Second-Quarter 2023 Results and Raises Full-Year 2023 Revenue Outlook

August 02, 2023

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Solidifies Leadership Team

August 01, 2023

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Will Release Second-Quarter 2023 Financial Results on August 2

July 11, 2023

From Bausch + Lomb Corporation

Via Business Wire

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.